DR REDDYS LABORATORIES LTD RDY

Latest FY: 2026 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $11.71
Market Cap $9.90B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2026) ↓-98.9% YoY
$3.58B
3-Yr CAGR: 6.2%
Net Income ↑535,525.0% YoY
$42.85B
Net Margin: 1,196.9%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
11.4%
ROA: 693.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (RDY)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $140,809.0M $78,356.0M 0.00%
FY 2018 $2,181.0M -98.5% $1,172.0M 0.00%
FY 2019 $2,225.0M +2.0% $1,206.0M $325.0M 0.00%
FY 2020 $2,316.0M +4.1% $1,247.0M $239.0M -26.5% 0.00%
FY 2021 $2,594.0M +12.0% $1,409.0M $361.0M +51.0% 0.00%
FY 2022 $2,826.0M +8.9% $1,500.0M $426.0M +18.0% 0.00%
FY 2023 $2,992.0M +5.9% $1,695.0M $734.0M +72.3% 0.00%
FY 2024 $279,164.0M +9,230.3% $1,963.0M $862.0M +17.4% 0.00%
FY 2025 $325,535.0M +16.6% $2,230.0M $8.0M -99.1% 0.00%
FY 2026 $3,580.0M -98.9% $1,889.0M $42,850.0M +535,525.0% 0.00%
$

Valuation

Market Price $11.71
Market Cap $9.90B
Enterprise Value $99.28B
P/E Ratio N/A
P/B Ratio 0.03
FCF Yield N/A
Dividend Yield 0.00%
Shares Outstanding 832,988,250
%

Profitability & Margins

Gross Margin 52.77%
Operating Margin 15.06%
Net Margin 1,196.93%
Return on Equity (ROE) 11.36%
Return on Assets (ROA) 693.93%
Asset Turnover 0.58x
Revenue 3-Yr CAGR 6.16%
🛡️

Financial Health & Liquidity

Current Ratio 1.80
Cash Ratio 0.00
Debt / Equity 0.237
Debt / Assets 14.501
Cash & Equivalents $164.00M
Total Debt $89.54B
Book Value / Share $452.66
💧

Cash Flow Efficiency

Operating Cash Flow N/A
Capital Expenditures (CapEx) $249.00M
Free Cash Flow N/A
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $452.66
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2026)

Total Assets $6.17B
Total Liabilities -$370.89B
Stockholders' Equity $377.06B
Current Assets $301.98B
Current Liabilities $167.57B